Start for free
Start for free
Trinitas Capital logo

Trinitas Capital

Asia, Beijing, China, Beijing

Description

Trinitas Capital is an investment company that mainly focuses on healthcare industries.

Investor Profile

Trinitas Capital has made 5 investments, with 0 in the past 12 months and 20% as lead.

Stage Focus

  • Series B (60%)
  • Series D (20%)
  • Series C (20%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Health Diagnostics
  • Pharmaceutical
  • Medical
  • Life Science
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Trinitas Capital frequently co-invest with?

Bristol-Myers Squibb
Bristol-Myers Squibb
North America, New York, United States, New York
Co-Investments: 1
Alexandria Venture Investments
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 1
Google Ventures
Google Ventures
North America, California, United States, Mountain View
Co-Investments: 1
Versant Ventures
Versant Ventures
North America, California, United States, Menlo Park
Co-Investments: 2
Frazier Healthcare Partners
Frazier Healthcare Partners
North America, Washington, United States, Seattle
Co-Investments: 1
The Column Group
The Column Group
North America, California, United States, San Francisco
Co-Investments: 2
Redmile Group
Redmile Group
North America, California, United States, San Francisco
Co-Investments: 1
Clarus Ventures
Clarus Ventures
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Lilly Asia Ventures
Lilly Asia Ventures
Asia, Shanghai, China, Shanghai
Co-Investments: 1
ARCH Venture Partners
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 3

What are some of recent deals done by Trinitas Capital?

HiberCell

New York, New York, United States

HiberCell is a clinical-stage biotechnology company dedicated to the advancement of novel therapeutic agents targeting adaptive stress.

BiotechnologyHealth CareHealth DiagnosticsMedical
Series BMay 19, 2021
Amount Raised: $67,400,000
Vividion Therapeutics

San Diego, California, United States

Vividion is a developer of a novel drug discovery platform designed to offer transformative treatments to patients with serious illnesses.

BiotechnologyHealth CareTherapeutics
Series BApr 30, 2019
Amount Raised: $82,000,000
ORIC Pharmaceuticals

South San Francisco, California, United States

ORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance.

BiopharmaBiotechnologyHealth CarePharmaceuticalTherapeutics
Series CFeb 21, 2018
Amount Raised: $50,000,000
Gritstone bio

Emeryville, California, United States

Gritstone bio is a biotechnology company that develops immunotherapies for cancer and infectious diseases.

BiotechnologyHealth CareTherapeutics
Series BSep 7, 2017
Amount Raised: $93,000,000
Quanterix

Billerica, Massachusetts, United States

Quanterix is a biotechnology company that develops ultrasensitive biomarker detection for healthcare.

BiotechnologyHealth CareHealth DiagnosticsLife SciencePharmaceutical
Series DMar 23, 2016
Amount Raised: $46,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator